or Try an Advanced Search...

    Technical Analysis for HYPR - Hyperfine, Inc.

    Grade Last Price % Change Price Change
    F 0.84 0.60% 0.01
    HYPR closed up 2.59 percent on Thursday, April 25, 2024, on 25 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 9
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical HYPR trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.60%
    Wide Bands Range Expansion 0.60%
    Oversold Stochastic Weakness 0.60%
    Lower Bollinger Band Walk Weakness 3.21%
    Wide Bands Range Expansion 3.21%
    Oversold Stochastic Weakness 3.21%
    Lower Bollinger Band Walk Weakness 2.08%
    Wide Bands Range Expansion 2.08%
    Lower Bollinger Band Touch Weakness 2.08%
    Oversold Stochastic Weakness 2.08%
    Older End-of-Day Signals for HYPR ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 2 hours ago
    Rose Above Previous Day's High about 3 hours ago
    Up 2% about 3 hours ago
    Up 1% about 3 hours ago
    Possible NR7 about 23 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    HYPR Chart by TradingView
    Basic chart:

    Profile

    Hyperfine was founded with a vision to save lives by making Magnetic Resonance Imaging (MRI) more accessible and affordable. Hyperfine's portable Swoop™ system is the world's first FDA-cleared bedside MRI system. Hyperfine was founded in 2014 by Jonathan Rothberg, Ph.D., a serial entrepreneur and the founder or co-founder of numerous other innovative companies, including CuraGen, 454 Life Sciences, Ion Torrent, RainDance Technologies, ClariFI, Quantum-Si, AI Therapeutics, Butterfly Network, 4Catalyzer, and 4Bionics. In 2015, Rothberg was awarded the National Medal of Technology and Innovation by President Obama for inventing and commercializing DNA sequencing.
    Classification
    Sector: Healthcare
    Industry: Medical Devices
    Keywords: Life Sciences Biology Natural Sciences FDA MRI Magnetic Resonance Magnetic Resonance Imaging DNA Sequencing Jonathan Rothberg

    Is HYPR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 23 Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions
    Apr 17 Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study
    Mar 21 Hyperfine, Inc. (HYPR) Q4 2023 Earnings Call Transcript
    Mar 21 Hyperfine GAAP EPS of -$0.15 beats by $0.03, revenue of $2.69M misses by $1.02M
    Mar 21 Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
    Mar 12 Hyperfine, Inc. Collaborates with King’s College London to Demonstrate the Swoop® System and UNITY Project to The Princess Royal
    Mar 7 Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024
    Feb 28 Hyperfine, Inc. to Present at the Oppenheimer 34th Annual Healthcare Conference
    Feb 21 Hyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes
    Feb 1 Hyperfine, Inc. Celebrates Breadth of Swoop® System Data Presented at the 2024 International Stroke Conference and Provides an Update on Enrollment in ACTION PMR Stroke Observational Study
    See more HYPR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.28
    52 Week Low 0.7951
    Average Volume 88,002
    200-Day Moving Average 1.52
    50-Day Moving Average 1.04
    20-Day Moving Average 0.94
    10-Day Moving Average 0.89
    Average True Range 0.08
    RSI (14) 35.48
    ADX 18.7
    +DI 12.10
    -DI 21.99
    Chandelier Exit (Long, 3 ATRs) 0.85
    Chandelier Exit (Short, 3 ATRs) 1.04
    Upper Bollinger Bands 1.09
    Lower Bollinger Band 0.78
    Percent B (%b) 0.16
    BandWidth 32.91
    MACD Line -0.06
    MACD Signal Line -0.05
    MACD Histogram -0.0124
    Fundamentals Value
    Market Cap 46.99 Million
    Num Shares 56.5 Million
    EPS -0.66
    Price-to-Earnings (P/E) Ratio -1.26
    Price-to-Sales 7.99
    Price-to-Book 0.78
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.90
    Resistance 3 (R3) 0.90 0.88 0.89
    Resistance 2 (R2) 0.88 0.86 0.88 0.89
    Resistance 1 (R1) 0.85 0.85 0.86 0.86 0.88
    Pivot Point 0.83 0.83 0.83 0.83 0.83
    Support 1 (S1) 0.80 0.81 0.82 0.81 0.78
    Support 2 (S2) 0.78 0.80 0.78 0.77
    Support 3 (S3) 0.76 0.78 0.77
    Support 4 (S4) 0.76